The EU drugs agency (EMCDDA) will present its annual assessment of Europe’s drugs problem in its Annual report 2011 to be released on 15 November in Lisbon. The report, the agency’s flagship publication, provides the latest data and commentary on the drug situation across the 27 EU Member States, Croatia, Turkey and Norway. Key challenges are discussed along with some of the promising practices used to address drug problems today. Where possible, European data are placed in a global context.
- Launch date: Tuesday 15 November 2011
- Time: 10:00 Western European Time (Lisbon) (11:00 Central European Time)
- Venue: Conference Centre, Cais do Sodré, 1249-289, Lisbon
The Annual report is part of a comprehensive package of information, to be available online on 15 November: www.emcdda.europa.eu/events/2011/annual-report
- Annual report — downloadable in 22 languages (21 EU plus Norwegian)
- Selected issues — offering in-depth reviews of the cost and funding of drug treatment; guidelines on the delivery of care; and mortality attributable to drug use
- Statistical bulletin — providing statistical tables and graphs
- Country overviews — presenting a brief synopsis of the trends and characteristics of national drug problems
- Reitox national reports — describing in detail the drug phenomenon in individual countries (English)
- Press pack — news releases downloadable in 22 languages
- MP3 files — conveying the Director’s comments on this year’s findings
- Interviews: EMCDDA scientific staff will be available on the day of the launch to answer journalists’ questions: Tel. (351) 211 21 02 00. Staff at the Reitox national focal points will answer country-specific queries (see contact details at www.emcdda.europa.eu/events/2011/annual-report).
